Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 27;10(6):1254.
doi: 10.3390/biomedicines10061254.

Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome

Affiliations
Review

Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome

Ana Teresa Brinca et al. Biomedicines. .

Abstract

Polycystic ovary syndrome (PCOS) represents one of the leading causes of anovulatory infertility and affects 5% to 20% of women worldwide. Until today, both the subsequent etiology and pathophysiology of PCOS remain unclear, and patients with PCOS that undergo assisted reproductive techniques (ART) might present a poor to exaggerated response, low oocyte quality, ovarian hyperstimulation syndrome, as well as changes in the follicular fluid metabolites pattern. These abnormalities originate a decrease of Metaphase II (MII) oocytes and decreased rates for fertilization, cleavage, implantation, blastocyst conversion, poor egg to follicle ratio, and increased miscarriages. Focus on obtaining high-quality embryos has been taken into more consideration over the years. Nowadays, the use of metabolomic analysis in the quantification of proteins and peptides in biological matrices might predict, with more accuracy, the success in assisted reproductive technology. In this article, we review the use of human follicular fluid as the matrix in metabolomic analysis for diagnostic and ART predictor of success for PCOS patients.

Keywords: human follicular fluid; metabolomics; polycystic ovary syndrome (PCOS); reproduction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Biomarkers of oxidative stress: (a) chemical structure of 8-Isoprostane; (b) chemical structure of 8-hydroxy-2′-deoxyguanosine.
Figure 2
Figure 2
Glucose and derivatives: (a) chemical structure of glucose; (b) chemical structure of lactate; (c) chemical structure of pyruvate; (d) chemical structure of glycerol.
Figure 3
Figure 3
Steroid hormones: (a) chemical structure of testosterone; (b) chemical structure of dihydrotestosterone; (c) chemical structure of estradiol; (d) chemical structure of estrone; (e) chemical structure of pregnenolone; (f) chemical structure of 17-Hydroxypregnenolone; (g) chemical structure of 17-Hydroxyprogesterone.
Figure 3
Figure 3
Steroid hormones: (a) chemical structure of testosterone; (b) chemical structure of dihydrotestosterone; (c) chemical structure of estradiol; (d) chemical structure of estrone; (e) chemical structure of pregnenolone; (f) chemical structure of 17-Hydroxypregnenolone; (g) chemical structure of 17-Hydroxyprogesterone.

Similar articles

Cited by

References

    1. Yu L., Liu M., Wang Z., Liu T., Liu S., Wang B., Pan B., Dong X., Guo W. Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome. Reprod. Biol. Endocrinol. 2021;19:74. doi: 10.1186/s12958-021-00749-6. - DOI - PMC - PubMed
    1. Ban Y., Ran H., Chen Y., Ma L. Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: A pilot study. J. Ovarian Res. 2021;14:135. doi: 10.1186/s13048-021-00885-y. - DOI - PMC - PubMed
    1. Chen W., Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites. 2021;11:869. doi: 10.3390/metabo11120869. - DOI - PMC - PubMed
    1. Liu R., Bai S., Zheng S., Zhu X., Zhang Y., Xu B., Zhao W. Identification of the Metabolomics Signature of Human Follicular Fluid from PCOS Women with Insulin Resistance. Dis. Markers. 2022;2022:1–10. doi: 10.1155/2022/6877541. - DOI - PMC - PubMed
    1. Broekmans F.J., Knauff E.A.H., Valkenburg O., Laven J.S., Eijkemans M.J., Fauser B.C.J.M. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG Int. J. Obstet. Gynaecol. 2006;113:1210–1217. doi: 10.1111/j.1471-0528.2006.01008.x. - DOI - PubMed

LinkOut - more resources